Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Vanassche, T.; Engelen, M. M.; Van Thillo, Q.; Wauters, J.; Gunst, J.; Wouters, C.; Vandenbriele, C.; Rex, S.; Liesenborghs, L.; Wilmer, A.; Meersseman, P.; Van den Berghe, G.; Dauwe, D.; Verbeke, G.; Thomeer, M.; Fivez, T.; Mesotten, D.; Ruttens, D.; Heytens, L.; Dapper, I.; Tuyls, S.; De Tavernier, B.; Verhamme, P.

doi:10.1186/s13063-020-04991-y

Trials

Article metrics
Last updated: Sat, 27 Apr 2024 1:36:50 Z

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Access & Citations

986

Article Accesses
2

Web of Science
3

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com